Crossmark

Hematopoietic Stem Cell Mobilization: Current Collection Approaches, Stem Cell Heterogeneity, and a Proposed New Method for Stem Cell Transplant Conditioning

Crossref DOI link: https://doi.org/10.1007/s12015-021-10272-1

Published Online: 2021-10-18

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Menendez-Gonzalez, Juan Bautista

Hoggatt, Jonathan https://orcid.org/0000-0002-6416-1634
Funding

Funding for this research was provided by:

National Heart, Lung, and Blood Institute (R00 HL119559, R01 HL144752)
License Information

Text and Data Mining valid from 2021-10-18

Version of Record valid from 2021-10-18
More Information

Article History

Accepted: 27 September 2021

First Online: 18 October 2021

Declarations

:

: N/A.

: N/A.

: JH and JBMG are alone responsible for the content and writing of the paper. JH and JBMG reviewed and approved the final version of the manuscript.

: JH is a founder and equity holder of Magenta Therapeutics and an equity holder of Moderna Therapeutics. JH has several patents related to hematopoietic mobilization.

Document is current

Any future updates will be listed below